The progression to AIDS is influenced by changes in the biology of heterogeneous mono- Cytosolic sensors of nucleic acids, restriction factors, and IFN-stimulated genes are induced in all three subsets with AIDS. We conclude that SIV infection alters the transcriptional relationship between monocyte subsets and that the innate immune response to SIV infection is conserved across monocyte subsets.
INTRODUCTION
In HIV and SIV infection, the progression to AIDS is associated with changes in monocyte biology including increased egress from the bone marrow, accelerated turnover, and increased activation. [1] [2] [3] [4] [5] [6] [7] Importantly, monocytes are phenotypically and functionally heterogeneous, and subpopulations differ with regard to immune function, activation status, migratory properties, and susceptibility to HIV or SIV infection. 4, [8] [9] [10] [11] Due to functional differences between monocyte subsets, perturbations to normal monocyte homeostasis and the relative proportion of each subset may influence disease progression. In humans and nonhuman primates, three populations of monocyte exist, Abbreviations: AFC, absolute fold change; CX3CR, chemokine (C-X3-C motif) receptor; DC, dendritic cell; dpi, days postinfection; GO, gene ontology; HIVE, HIV encephalitis; ISG, IFN-stimulated gene; IACUC, Institutional Animal Care and Use Committee; MFI, mean fluorescence intensity; qRT-PCR, quantitative real-time PCR; SIVE, SIV encephalitis defined by expression of CD14 (LPS coreceptor) and CD16 (Fc RIII):
classical (CD14++CD16-), intermediate (CD14++CD16+), and nonclassical (CD14+CD16++) monocytes. 4, 12, 13 The developmental relationship between monocyte subsets and the specific role of each in HIV and SIV pathogenesis are not known.
Current understanding of the biology of monocyte subpopulations comes from studies in humans and macaques and homologous monocyte populations in mice. 14, 15 In humans, circulating monocytes are composed of approximately 80% classical monocytes, 5% intermediate monocytes, and 10% nonclassical monocytes. 4, 13, 16 Classical monocytes exhibit high phagocytic ability and produce reactive oxy-activation, and may be a transitional population between classical and nonclassical monocytes. 4, 13 In response to LPS, intermediate monocytes produce TNF-and IL-1 . 16 Nonclassical monocytes migrate along the luminal face of the vasculature, express chemokine (C-X3-C motif) receptor (CX3CR1; fractalkine receptor), and may extravasate into tissue to replenish resident macrophage populations. 4, 12, 13, 16, 18 In response to TLR7/TLR8 agonists (viruses, nucleic acids), nonclassical monocytes produce proinflammatory cytokines TNF-, IL-1 , and CCL3/MIP-1 . 16 Thus, monocyte subsets differ in abundance, phenotype, migratory ability, and response to immune stimuli.
The progression to AIDS and the incidence of CNS disease are directly influenced by monocyte dysregulation in HIV and SIV infection. 6, [20] [21] [22] Previous gene array studies regarding gene regulation in ex vivo monocytes in the context of HIV infection have identified a number of affected pathways including macrophage activation, chemotaxis, cell cycle, apoptosis, lipid metabolism, proteasome function, and transcriptional regulation. 2, [23] [24] [25] [26] [27] With HIV or SIV infection, increased numbers of circulating monocytes and increased monocyte activation correlate with the development of viral encephalitis (HIV encephalitis [HIVE] and SIV encephalitis [SIVE] ) and dementia. 3, [28] [29] [30] [31] The gene expression profile of CD14+ monocytes from HIV-1+ patients is similar to the gene expression profiles of uninfected monocytes stimulated with type-I IFN and uninfected monocytes stimulated with Staphylococcus aureus, a TLR2 agonist. 27, 32 Additionally, CD14+ monocytes from HIV-1+ individuals with high viral loads were shown to upregulate macrophage-associated genes involved in chemotaxis and inflammatory response, underscoring the role of activated monocytes as precursors to tissue macrophages in HIVE. 2 In vivo, the frequency of productively infected monocytes is low (<0.1%); however, the mean half-life of HIV-1 DNA in monocytes was found to be greater than 40 months in spite of effective antiretroviral therapy. 10, [33] [34] [35] [36] Given the low frequency of infection, changes in monocyte biology are most likely the result of systemic immune activation, altered cytokine signaling, and other indirect mechanisms resulting from chronic HIV or SIV infection. CD16+ monocytes are more permissive to HIV and SIV infection compared to CD16-monocytes, and are preferentially infected in vivo. 6, 10 Historically in HIV research, many studies have focused on the role of activated CD14+CD16+ monocytes (intermediate monocytes), which expand with inflammation and are precursors of tissue macrophages. 3, 5, 7, 28, 30, 31, 37, 38 In HIVE, increased activation and expansion of the intermediate subset is thought to be associated with traffic of virus across the bloodbrain barrier and accumulation of inflammatory macrophages in the CNS. 6, 37, 39 Specific roles for classical and nonclassical monocytes in HIV and SIV pathogenesis are not well characterized. With a new view of monocyte heterogeneity, it is necessary to define the shared and unique biology of the three monocyte subsets and the role each plays in HIV pathogenesis.
We performed transcriptional analysis of the three monocyte subpopulations in rhesus macaques (n = 4) at three time points: (1) prior to SIV infection, (2) at 26 days postinfection (dpi), and (3) at necropsy, terminally with AIDS. We found that the majority of markers that differentiate monocyte subsets in uninfected animals are not differentially expressed between monocyte subsets in SIV-infected animals.
Transcripts that identify classical and nonclassical monocytes in humans and mice were conserved in rhesus macaques. We found that classical monocytes expressed transcripts associated with proliferation, wound repair, and response to immune stimuli, while nonclassical monocytes expressed transcripts associated with macrophage phenotype, withdrawal from cell cycle, and immune effector functions. Intermediate monocytes were more similar to classical monocytes than nonclassical monocytes, but showed increased transcriptional similarity to nonclassical monocytes terminally with AIDS. Changes to monocyte gene expression occurred within weeks of primary infection and were sustained throughout the course of infection. Transcripts associated with innate immune response, particularly IFN-stimulated genes (ISGs), were induced in all monocyte subsets in SIV-infected animals.
These studies indicate that the set of expressed genes associated with each monocyte subset is altered with SIV infection, but each subset retains its putative functional characteristics. Additionally, the innate immune response to SIV infection, including induction of ISGs, is conserved across monocyte subsets.
MATERIALS AND METHODS

Ethics statement
All animals were handled in accordance with good animal practice as defined by the Tulane National Primate Research Center's Institutional Animal Care and Use Committee (IACUC). All animal work was approved by this committee and the IACUC of Boston College.
Animals and treatments
Four adult male rhesus macaques (animal ID: CM07, DB79, FD05, FB92) were infected i.v. with 1 ng of SIVp27 of SIVmac251, a generous gift from by Ronald Desrosiers. CD8+ lymphocytes were depleted in order to achieve rapid progression to AIDS with a >75% incidence of SIVE. 3, 7, [40] [41] [42] The chimeric anti-CD8 antibody cM-T807 (NIH Nonhuman Primate Reagent Resource) was administered s.c. (10 mg/kg) at 6 dpi and i.v. (5 mg/kg) on 8 dpi and 12 dpi as previously described. 3, 30 Complete blood counts and flow cytometry to monitor leukocyte populations were performed prior to infection and weekly throughout the course of the disease.
SIV-infected animals were sacrificed with any of the following criteria, indicative of AIDS when present: >15% decrease in body weight in 2 weeks or >30% decrease in body weight in 2 months; documented opportunistic infection; persistent anorexia >3 days without explicable cause; severe, intractable diarrhea; progressive neurological symptoms; significant cardiac or pulmonary symptoms. Prior to sacrifice, animals were anesthetized with ketamine-HCl and euthanized by an 
Viral load determination
SIV RNA in the plasma was quantitated by real-time PCR as previously described. 46 SIV virions were pelleted from 0.5 ml EDTA plasma by centrifugation at 20,000 g for 1 h. The fluorescently labeled, real-time PCR probe employed contained a nonfluorescent quencher, BHQ-1, at its 3 ′ end. The threshold of sensitivity was 100 copy equivalents/ml, with an average interassay coefficient of variation of less than 25%.
Isolation of monocyte subpopulations for microarray analysis
Prior to infection, at 26 dpi, and at necropsy, mononuclear cells were isolated from 10 ml EDTA-treated whole blood (n = 4 animals: CM07, DB79, FD05, FB92) by density gradient centrifugation over FicollHypaque (GE Healthcare, Chicago, IL). Buffy coats were collected and washed in calcium-and magnesium-free PBS and stained for 15 min with anti-CD14-PacificBlue, anti-CD16-PE, anti-HLA-DR-PerCP-Cy- 
Microarray processing
RNA extraction, labeling, and hybridization were performed by the Beth Israel Deaconess Medical Center Genomics Core Laboratory as previously described. 47, 48 Briefly, total RNA was extracted with TRIzol (Life Technologies, Carlsbad, CA) according to the manufacturer's instructions. RNA quality at all steps was assayed on an Agilent 2100 Bioanlayzer (Agilent Technologies). RNA (>500 pg) was amplified using the Ovation pico WTA system (NuGEN Technologies Inc., San Carlos, CA). cDNA (20 g) was fragmented as described and hybridized with a preequilibrated Affymetrix GeneChip Rhesus Macaque Genome Array (Affymetrix, Santa Clara, CA) at 45 • C for 16 h. After the hybridization cocktails were removed, the chips were washed, stained, and scanned according to the manufacturer's protocols as previously described. 47 The microarray data files were deposited in the Gene Expression Omnibus, accession GSE98717 (https://www.ncbi.nlm.nih.gov/geo).
Microarray data analysis
The gene expression data generated (>47,000 rhesus transcripts interrogated per array) were analyzed with Partek Express Genomics Suite software (Partek Inc., Chesterfield, MO). The data were normalized by using a robust multichip average algorithm. 49, 50 Quality control measures included assessment of labeling controls, hybridization controls, 3 ′ /5 ′ ratio, mean raw probe intensity, mean absolute deviation across chips, and mean relative log expression. Due to the low abundance of the nonclassical monocyte subset, insufficient RNA was isolated from this population at preinfection from animals FD05 and FB92, and at necropsy from animal CM07. These samples did not meet quality control parameters and were excluded from further analysis.
Statistical analysis
Partek Express was used to identify genes that were that were significantly (P < 0.05), differentially expressed across monocyte subset or SIV infection time point with a 5% false discovery rate. Heatmaps were generated using dChip software. 51 Gene lists were subjected to functional annotation clustering with DAVID bioinformatics tools to identify enrichment clusters associated with specific biological processes according to gene ontology (GO) annotations. 52, 53 Statistical significance of the expansion of monocyte subsets ( (Table 1) was determined by t test using Spearman's R.
qRT-PCR for microarray validation
RNA from each sample was extracted with TRIzol as indicated above.
First-strand cDNA was generated from >40 ng total RNA with Superscript III first strand synthesis kit (Invitrogen, Carlsbad, CA 
RESULTS
Monocyte populations expand with SIV infection
The absolute number and relative percentage of each monocyte subset were determined for each animal (n = 4): (1) prior to infection, (Supplemental Table 1 ). At the same time points, monocytes were isolated for gene expression analysis. We chose to include 26 dpi because of our previous BrdU labeling studies that indicate this is a pathogenically important time point in early SIV infection when monocyte expansion from bone marrow increases. 3, 7 Animals that have greater than 5% BrdU positive monocytes in blood 24 h after BrdU pulse consistently develop rapid AIDS with SIVE and cardiovascular lesions. 3, 7 Prior to infection, classical monocytes accounted for 196 ± 56 cells/ l 
Isolation of monocyte populations and microarray analysis
At each collection time point, PBMCs were isolated from EDTA anticoagulated whole blood by FACS (Supplemental Table 1 
Identification of transcripts that differentiate monocyte subsets or infection time points
To identify differentially expressed transcripts, gene expression data from each of the four animals were grouped and compared based on the variables of interest: monocyte subset and infection time point.
A total of 3418 probe sets were identified as significantly, differentially expressed between monocyte subsets and 665 were identified as significantly, differentially expressed between infection time points. This list was then filtered based on an absolute fold change (AFC) ≥2.0 between monocyte subsets or infection time points and a P-value < 0.05 by ANOVA followed by pairwise comparisons with
Benjamini-Hochberg correction. Probe sets were annotated with the corresponding human official gene symbol and redundant probe sets representing the same gene and probe sets representing hypothetical genes were removed. In agreement with the observed effect sizes, we found 2023 genes that were significantly, differentially expressed between monocyte subsets in at least one time point and 424 genes that were significantly differentially expressed between infection time points in at least 1 monocyte subset.
Validation of microarray data by qRT-PCR and FACS
To validate the microarray expression data, we generated cDNA from 
Gene signature of monocyte subsets in uninfected animals
In order to characterize genes specific to each monocyte subset in uninfected animals, we selected genes that were differentially expressed in each subset compared to the other two subsets ( 
Invariant gene signature of monocyte subsets with SIV infection
Of the 813 genes expressed in a subset-specific manner preinfection, only 172 genes were also subset-specific at 26 dpi and terminally with AIDS ( Figure 3B ). Ten genes were consistently expressed ≥2.0-fold by classical monocytes than by other subsets, including S100A8, S100A9, and SELL (L-selectin, CD62L) ( Figure 3B ). These genes are expressed by classical monocytes in humans and mice ( Figure 3B ). TREM1  INSIG1  EGR2  SSH2  NDUFB2  CLEC4A  CYBRD1  LSG1  ZEB2  C5AR1  PXK  CD1B  PON2  OLFM1  SDC2  RUNX2  ADO  JARID2  NUS1  PTPLAD2  LGALS3  PCYOX1L  KLF10  TMED5  AAK1  CCDC88A  EEF1A1  ZAK  AGPAT9  PID1  GAS7  THBS1  MS4A6A  ANXA1  LASS6  PADI2  GPX1  SLC2A3  FN1  HNRPLL  OSM  ACSL1  TCEAL4  GPATCH2  LYZ  NQO2  CD163a  TMEM49  VMP1  S1PR2  VEGFA  DEPDC1  RUNX1  P2RY2  TUBA3  SLC22A4  FCAR  CRISPLD2  CCR1  FCGR2B  DCP2  CD14   VCAN  IL13RA1  CCR2  TFEC  FCGR1B  P8  RAB3D  PYGL   ZCCHC9   SERPINB10  QPCT  NRG1  S100A8   S100A9  HIST1H2BB  LTB4DH  MGST1   DNM1  RAMP2  PALLD  PRR5L  SPN  CD300E  SEPP1  FCGR3A  FCGR3B  C11orf95  ITGAL  ADA  TOB1  TCF7L2  SASH1  HTR7A  PSMC2  ULK2  PLVAP  C1QA  ITGAD FOSL2  TGFBR1  JUN  HIF1A  VEGFA  TGFBR2  NAMPT  RUNX2  HBEGF  CDC25B   OSM  MALT1  PPP2CA  NEK6  WLS  HIPK3  IL6ST  ZAK  SEMA4C  NENF   RABEPK  CD93  AP1G1  LDLR  CORO1C  FCGR1A  RIN1  RAC1  CD14  MSR1   NRG1  SERPINB2  F3  TGFBR2  THBD  PROZ  ELK3  F13A1  SERPINA1  ENTPD1   PAG1  ADA  THY1  STAT5A  BTLA  CD47  TNFRSF14  SPN  CD83  CD4   IL21R  TNF  LYN  LTB  PIK3R1  ITGAL  WAS  CD48  SPN  HSPD1   CDKN1C  TOB1  CASP3  IFITM1  ADORA2A  LTB  BTLA  SMARCA2  TESC  INPP5D   CCL5  TNF  CX3CR1  C1QB  ITGB2  C1QC  ITGAL  CD48  SPN  CD83   N  C  C I   CX3CR1  AKT3  MS4A7  CCL5  LTB  SLC44A2  CD247  GZMB  BTLA  THY1  SCAMP5  SLC9A9  AHNAK2  EEF2K  CACNA1A  FAM126B  ST3GAL6  TNF  CDKN1C  MTSS1L  DUSP5  IFT81   3  7  11 
In silico analysis of gene-associated functions suggests classical monocytes are immune sensors and nonclassical monocytes are immune effectors
In order to investigate whether the genes that were differentially expressed between the monocyte subsets were associated with specific biological processes, we performed an in silico analysis using DAVID bioinformatics tools. 52, 53 Human official gene symbols were used in order to take advantage of the relative abundance of gene annotation data for humans relative to macaques. With DAVID tools, gene lists were annotated with the GO terms for biological processa controlled vocabulary for describing the biological function of gene products-and statistically overrepresented GO terms were identified. The analysis was performed for each of the infection time points (Table 2) . Interestingly, we found that the GO terms that were enriched for each subset were generally the same in uninfected and SIV-infected animals, suggesting that the functional role of each subset is maintained with SIV infection and inflammation (Table 2) .
In uninfected and SIV-infected animals, the genes specifically expressed by classical monocytes or both classical and intermediate monocytes were enriched for biological processes including defense response, positive regulation of cell proliferation, regulation of protein kinase cascade, endocytosis, and wound healing ( Figure 3C and Table 2 ). Defense response genes expressed in classical monocytes include inflammatory mediators (e.g., IL-8, S100A8, and S100A9).
Interestingly, S100A9 and the S100A8/S100A9 heterodimer comprise the epitope recognized by the antibody MAC387, which defines a subset of macrophages that is recruited in response to inflammation. 41, 54 Both Table 2 TA B L E 2 GO terms for biological process enriched in the set of genes differentially expressed across monocyte subsets C, classical; I, intermediate; N, nonclassical; #, number of queried genes associated with the GO term; %, (# GO associated genes/total genes queried) × 100; NS, not significant; P-value for enrichment of the GO term: * P ≤ 0.05, ** P < 0.01 *** P < 0.001, P < 0.0001.
enriched in nonclassical monocytes are consistent with this subset having exited the cell cycle, mediating immune effector functions, producing chemoattractant ligands, and being able to extravasate vessels to become tissue macrophages.
Changes in monocyte gene expression occur early in SIV infection
To investigate subset-specific changes in gene expression with SIV infection, we identified genes that were differentially expressed (≥2.0 AFC) between infection time points for each monocyte subset (Figure 4A) . Between preinfection and necropsy, more genes were differentially expressed in the nonclassical subset (265 genes) than in the classical (227 genes) or intermediate subsets (202 genes) ( Figure 4A ).
In all subsets, the majority of changes in gene expression had occurred by 26 dpi, indicating that changes in gene expression due to SIV infection are established early ( Figure 4A ). The majority of genes differentially expressed at 26 dpi were upregulated relative to preinfection in the classical and intermediate subsets. In the nonclassical subset, upregulated and downregulated genes were present in approximately equal numbers ( Figure 4A ). Between 26 dpi and necropsy, the majority of differentially expressed genes were downregulated relative to 26 dpi ( Figure 4A ). Many of these downregulated genes were transcription factors. These data suggest that changes to monocyte gene expression occur early in SIV infection. Additionally, we observed that the pattern of changes in gene expression with SIV infection is more similar between classical and intermediate monocytes compared to nonclassical monocytes.
Characterization of the monocyte immune response to SIV infection
We next sought to characterize the immune response of each mono- SLFN13   ICAM1  PIAS1  CD44  IRF4  HLA-DPB1  IRF8  AKIRIN2  CAPZA2  ADAR  TRIM5  CFB  RARRES3  IFIT3  AIM2  IFITM1  PLA2G12A  IL1RN  IFITM3  GBP2  IFIT1  DDX58  HERC6  CASL  PML  OAS3  UBE2L6  APOBEC3A  SAMHD1  DDX60  ISG20  ZBP1  ISG15  RNF213  AMBP  TRIM14  IRF7  OAS1  OAS2  RSAD2  MX1  MX2  IFI27  GBP1  USP18  PON2  LY96  STAT2  CD300LF  SP100  CD163  JAK2  JUN  S100A9  APOBEC3F  HLA-B  LCN2  FCN2  SOCS3  CD300E  PTAFR  C1QC  CXCL16   IFITM3  IFIT1  GBP1  GBP2  OAS2  MX1  MX2  IRF7  USP18  ISG20  ZBP1  ISG15  OAS1  IFI27  OAS3  SLFN5  IFIT3  SAMD9  AIM2  IFITM1  STAT2  PML  OASL  IFI44  SP100  EIF2AK2  ADAR  PTAFR  IFI16  LY6E  LGALS3BP  JAK2  HLA-B  SOCS3  CXCL16  ICAM1  PIAS1  IRF4  CD44  HLA-DPB1  IRF8   CTLA4  CD3E  CD2B  CD5  HSPD1  LY6E  RNF144B  GIMAP6  GIMAP1  HMOX1  IDO1  IRF7  SIGLEC1  FCGR2A  ADAMDEC1  GIMAP4  ICAM1  CD74  C1QC  CD8a  IRF4  IL1B  ADORA2B 
DISCUSSION
In this study, we identify changes in the gene expression profile of classical, intermediate, and nonclassical monocytes with SIV infection. We found that only 172 of 813 genes differentially expressed between monocyte subsets prior to infection remained differentially expressed in SIV-infected animals. In this study, we show that in uninfected and SIV-infected macaques classical monocytes express CD62L/SELL, S100A8, and S100A9, while nonclassical monocytes express CX3CR1.
These markers are also differentially expressed between classical and nonclassical monocytes in humans and mice. 13, 18 The chemokine and Fc receptors Fc RIa, CCR1, and CCR2, which are expressed on classical monocytes and not intermediate monocytes in humans and mice, were expressed on both classical and intermediate monocytes in rhesus macaques. 13, 15 Few markers uniquely differentiate the intermediate subset as they share markers with classical and nonclassical monocytes. We identified two genes in macaques specific to intermediate monocytes whose proteins are known to be expressed on the cell surface: MERTK and C3AR1. In humans, the receptor tyrosine kinase MERTK is a marker of intermediate monocytes, and C3AR1 was reported to be more highly expressed in CD16+ monocytes. 11, 13 MERTK is involved in leukocyte migration, clearance of apoptotic cells, inhibition of lymphocyte activation, and has been linked to susceptibility to multiple sclerosis. 58 The subset-specific genes identified herein may provide useful markers of the individual monocyte subsets in uninfected and SIV-infected animals.
Genes expressed by classical monocytes were associated with defense response, proliferation, and wound healing. Expression of CCR1, CCR2, and CD62L suggests that classical monocytes can be mobilized in response to CCR1 and CCR2 ligands (CCL2/MCP-1, CCL7/MCP-3, CCL5/RANTES), home to lymphoid organs or sites of inflammation (via CD62L/SELL), and mediate inflammation or wound healing. Classical monocytes also express transcripts for S100A8 and S100A9 whose proteins comprise the antigen (calprotectin, S100A8/S100A9) recognized by the antibody MAC387. 54, 59 MAC387 has been used to identify a population of inflammatory macrophages that is recruited to the CNS in response to acute inflammation. 41, 54, 59 Notably, MAC387+ macrophages present in SIVE lesions were found We found that intermediate monocytes and classical monocytes share more expressed genes in macaques, whereas intermediate monocytes and nonclassical monocytes share more expressed genes in humans. 9 This suggests that the biology of monocyte subsets may vary between humans and nonhuman primates. We found high interanimal variability in gene expression, which indicates that the genes identified as differentially expressed in a given study will be greatly affected by the subject pool. Additionally, the genes identified in these studies may be affected by the depletion of CD8+ lymphocytes. Studies of SIV infection without CD8+ depletion and in HIV-infected humans are necessary to validate the findings herein. Studies that evaluate the effect of antiretroviral therapy on gene expression in monocyte subsets and associated changes in disease progression are also needed.
Comparing early and end-stage disease, we observed that the majority of changes in gene expression were present by 26 dpi and were then sustained throughout infection. We have previously shown that increased monocyte egress from the bone marrow is detectable within weeks of primary infection. 3 The magnitude of the expansion of blood monocytes is predictive of how rapidly the animals progress to AIDS and the severity of macrophage-mediated, AIDSrelated pathogenesis. 3 We can consistently detect or predict by day 26 postinfection which animals will develop rapid AIDS and CNS and cardiac pathology. 3, 61 This suggests that monocyte dysregulation with SIV infection is present early after infection and prior to AIDS onset.
Although intermediate monocytes have been the primary focus of previous research, we observed that the nonclassical subset had the greatest number of genes that were differentially expressed with SIV infection. Moreover, expansion of these cells correlates with AIDSrelated pathologies including CNS and cardiac disease. 3, 28, [61] [62] [63] This suggests that nonclassical monocytes merit additional focus going forward. Because nonclassical monocytes are innate effector cells, likely precursors to tissue macrophages, and regulators of adaptive immunity, changes to nonclassical monocyte biology may have varied effects.
It is likely that these cells expand in response to macrophage turnover in the lymph nodes with AIDS and as a general innate immune response to tissue damage. 3, 7 Further studies to elucidate the mechanisms and consequences of monocyte dysregulation in early SIV infection are needed.
We found that ISGs were upregulated in all three monocyte subsets by 26 dpi and terminally with AIDS indicating a sustained IFN response that likely indicates ongoing immune activation that may contribute to exhaustion of the immune system with chronic SIV infection. IFN , which is produced primarily by plasmacytoid DCs in response to TLR signaling, has been implicated as a major mediator of chronic immune activation in HIV and SIV infection. 25, 27, [64] [65] [66] Although the direct effect of HIV or SIV on monocytes is likely limited by the low frequency of infected monocytes, the effects of IFN-signaling on monocytes may be more widespread. Gene array studies of CD14+ monocytes from HIV-infected patients and whole blood from SIV-infected rhesus macaques have demonstrated a robust and sustained induction of ISG. 26, 27, 64, 65 In humans, greater monocyte ISG induction is associated with higher viral load and increased neuronal damage, suggesting a link between type-I IFN responses and HIVE. 26, 27 Importantly, comparisons between pathogenic infection of humans and rhesus macaques, and nonpathogenic infection of sooty mangabeys or African green monkeys have demonstrated that increased IFN-production and failure to downregulate ISG induction after acute viremia are associated with pathogenic infection. [64] [65] [66] We also observed upregulation of genes associated with detection of cytosolic nucleic acids and host restriction factors (APOBEC3A, TRIM5, SAMHD1), which may contribute to limited infection of monocytes in vivo. Despite heterogeneity of monocyte subsets, the pattern of induction of ISG and genes associated with innate immunity was similar between the three monocyte subsets, indicating a conserved immune response to SIV infection. The in vivo CD8 T lymphocyte depletion antibodies used in these studies were provided by the NIH Nonhuman Primate Reagent Resource (R24 OD010976, and NIAID contract HHSN 272201300031C). We thank the veterinary staff at the TNPRC for animal care, Cecily Conerly Midkiff and staff for assisting with tissue collection. We thank
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